Skip to main content
Industry News
DMI receives $1.5M grant for FVIII, emicizumab test
10/13/2020

The DNA Medicine Institute received a $1.5 million grant from the National Institutes of Health to aid in the development of its fingerstick point-of-care technology that monitors Helimbra, or emicizumab, and factor VIII blood levels in people with hemophilia A.

Full Story: